Chicago Partners Investment Group LLC Acquires New Position in Evolent Health, Inc. (NYSE:EVH)

Chicago Partners Investment Group LLC acquired a new stake in shares of Evolent Health, Inc. (NYSE:EVH) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 7,351 shares of the technology company’s stock, valued at approximately $228,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in EVH. Signaturefd LLC increased its position in Evolent Health by 1,470.7% during the 4th quarter. Signaturefd LLC now owns 1,445 shares of the technology company’s stock valued at $48,000 after purchasing an additional 1,353 shares during the period. NBC Securities Inc. purchased a new position in shares of Evolent Health in the 4th quarter worth approximately $69,000. Strs Ohio grew its position in shares of Evolent Health by 46.3% in the 4th quarter. Strs Ohio now owns 6,000 shares of the technology company’s stock worth $198,000 after buying an additional 1,900 shares during the last quarter. Johnson Investment Counsel Inc. purchased a new position in shares of Evolent Health in the 4th quarter worth approximately $209,000. Finally, Xponance Inc. purchased a new position in shares of Evolent Health in the 4th quarter worth approximately $222,000.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. Canaccord Genuity Group cut their price objective on shares of Evolent Health from $44.00 to $41.00 and set a “buy” rating on the stock in a research report on Friday, May 10th. Oppenheimer began coverage on shares of Evolent Health in a research report on Friday, March 1st. They set an “outperform” rating and a $45.00 target price on the stock. JMP Securities dropped their target price on shares of Evolent Health from $38.00 to $34.00 and set a “market outperform” rating on the stock in a research report on Friday, May 10th. JPMorgan Chase & Co. dropped their target price on shares of Evolent Health from $53.00 to $52.00 and set an “overweight” rating on the stock in a research report on Friday, March 15th. Finally, Citigroup began coverage on shares of Evolent Health in a research report on Monday, April 22nd. They set a “buy” rating and a $40.00 target price on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $42.00.

Evolent Health Stock Performance

EVH opened at $22.07 on Wednesday. The stock has a market cap of $2.56 billion, a P/E ratio of -17.66 and a beta of 1.44. The firm has a fifty day moving average price of $25.41 and a 200 day moving average price of $29.35. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.02 and a quick ratio of 1.02. Evolent Health, Inc. has a 1 year low of $20.54 and a 1 year high of $35.00.

Evolent Health (NYSE:EVH) last issued its quarterly earnings results on Thursday, May 9th. The technology company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.12 by $0.04. The company had revenue of $639.65 million during the quarter, compared to analyst estimates of $601.60 million. Evolent Health had a negative net margin of 5.07% and a positive return on equity of 6.90%. Equities research analysts anticipate that Evolent Health, Inc. will post 0.9 earnings per share for the current year.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.